Archives
-
Cross-Talk in Teicoplanin and A40926 Biosynthesis
2026-09-08
The 2023 reference study tested whether pathway-specific regulators from teicoplanin and A40926 biosynthetic clusters could function interchangeably across producing organisms. Its cross-complementation experiments revealed strong functional differences between related StrR-like regulators, while LuxR-like regulators were more transferable and could even enhance teicoplanin production.
-
5-hme-dCTP Workflows for 5hmC Research
2026-09-07
Use 5-hme-dCTP to build defined hydroxymethylated DNA controls, compare DNA polymerase acceptance, and strengthen DNA hydroxymethylation assay design. The workflow connects practical reagent handling with rice drought-response findings without confusing an in vitro substrate with a direct detector of endogenous 5hmC.
-
ALDOB K87 Lactylation in Pulmonary Hypertension
2026-09-07
A 2026 Communications Biology study identifies ALDOB K87 lactylation as a metabolic switch linking hypoxia-induced glycolysis to DRP1-dependent mitochondrial fission in pulmonary hypertension. The work combines lactylomic profiling, pulmonary artery smooth muscle cell models, rodent validation, and genetic or pharmacological perturbation to define a lactate–ALDOB–DRP1 axis that promotes vascular remodeling.
-
Pcbp1, Mitochondria, and B Cell Antibody Responses
2026-09-05
Zhu and colleagues identify the RNA-binding protein Pcbp1 as an upstream regulator of mitochondrial integrity, protein translation, and humoral immunity in B cells. The study links Pcbp1 binding to the Fdxr 3′ untranslated region with preservation of complex I function, reduced mitochondrial reactive oxygen species, antibody production, and germinal center responses.
-
Nipah Virus Polymerase Complex: Structural Insights
2026-09-04
Balıkçı and colleagues provide cryo-EM and crystallographic views of the Nipah virus L–P polymerase complex, defining how the catalytic L-protein is organized and how tetrameric P-protein associates with it. The work also identifies a three-magnesium-ion configuration in the connecting domain and proposes a role for one ion in mRNA capping, creating a structural framework for rational antiviral research.
-
Patient-Specific PDAC Co-Culture Models and Chemoresistance
2026-09-04
Schuth et al. developed a patient-matched three-dimensional co-culture model combining pancreatic ductal adenocarcinoma organoids with cancer-associated fibroblasts. The system showed that stromal fibroblasts increased organoid proliferation, reduced chemotherapy-induced cell death, and promoted transcriptional programs consistent with epithelial-to-mesenchymal transition, providing a more physiologically informative platform for drug-response studies.
-
2,2,2-Trichloroethanol Protein Workflows
2026-09-03
Use 2,2,2-Trichloroethanol as a controlled protein-analysis variable rather than a one-size-fits-all additive. This guide connects electrophoresis quality control with dopamine-neuron maturation studies while clearly separating supported evidence from exploratory assay recommendations.
-
Direct Mouse Genotyping Kit: PCR Workflow
2026-09-03
The Direct Mouse Genotyping Kit supports PCR amplification from mouse tissue lysates without conventional DNA purification, helping laboratories simplify routine mouse genetic screening. It is intended for PCR-based genotyping rather than recovery of highly purified genomic DNA for unvalidated downstream enzymatic workflows.
-
(S)-(+)-Methoprene: Causal JH Assay Design
2026-09-02
Discover how (S)-(+)-Methoprene can separate juvenile hormone receptor signaling from endogenous hormone biosynthesis. This article translates miRNA–mRNA findings into rigorous assay designs for developmental endocrinology, metamorphosis, and arthropod toxicology.
-
Dexamethasone: Genotype-Aware Assay Design
2026-09-02
Dexamethasone is a glucocorticoid anti-inflammatory research tool whose effects depend on cellular state, genotype, and endpoint selection. This guide combines DHAP mechanism with multiple myeloma cell-line genomics to improve model choice, controls, and interpretation across inflammation, stem-cell, lymphoblastic, and neuroinflammation assays.
-
Mdivi-1 and ECM–Mitochondria Signaling
2026-09-01
Mdivi-1 is a selective DRP1 inhibitor that connects mitochondrial fission, apoptosis, and stress adaptation. This article interprets its use through the newly defined ECM-to-mitochondria signaling axis, offering a context-aware framework for mitochondrial dynamics research.
-
5hmC in Rice Drought: A Translational Playbook
2026-09-01
5-hme-dCTP and 5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate provide a defined substrate for investigating DNA hydroxymethylation, polymerase behavior, and epigenetic assay performance. Building on a rice drought-response study, this article outlines how translational researchers can move from chemical controls to context-aware gene expression regulation studies and crop resilience research.
-
5-Methyl-CTP for Robust mRNA Synthesis
2026-08-31
5-Methyl-CTP helps researchers test whether cytidine methylation improves mRNA durability and protein output in controlled in vitro transcription workflows. Its value extends from gene-expression assays to delivery studies, including personalized vaccine platforms that require both high-quality RNA cargo and efficient cellular presentation.
-
LNP Surface Charge and V-ATPase Drive Delivery
2026-08-31
The reference study proposes that lipid nanoparticle (LNP) tropism is determined by a synergy between particle surface charge and the endo/lysosomal V-ATPase activity of target cells. Its in vitro and in vivo findings shift attention from nanoparticle design alone toward matching vector properties with the functional state of recipient tissues.
-
RCN2–UBR5–PPP2CA Axis in ESCC Resistance
2026-08-30
The reference study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent ubiquitination and degradation of PPP2CA, which activates PI3K-AKT signaling. Its multi-omics and biochemical validation strategy provides a framework for testing pathway-directed interventions while highlighting the need to distinguish direct evidence from broader PI3K/Akt/mTOR signaling hypotheses.